Progress in the detection and targeted therapy of epidermal growth factor receptor variant III in ovarian cancer

Abstract

Abstract: The epidermal growth factor receptor variant III (EGFRvIII) also known as the most common mutant form of EGFR is a tumor-specific mutation, hasn’t yet been detected in normal tissues. It is regarded as a tumor-specific gene and offers a new way for targeted therapy of ovarian cancer.

Key words: epidermal growth factor receptor, epidermal growth factor receptor variant III, ovarian cancer, targeted treatment

CLC Number:

Cite this article

share this article

/ Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal11.magtechjournal.com/Jwk_jcyxylc/EN/

https://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2015/V35/I11/1567

References

Related Articles 15

[1]	TIAN Ye, HE Quan, WANG Xiaojuan. RPRD1B is highly expressed in human ovarian cancer cell lines and promotes tumor cell proliferation [J]. Basic & Clinical Medicine, 2025, 45(8): 1066-1072.
[2]	ZHANG Xue, WANG Jiyuan, GAO Shuangxia, GUO Zhankun, LI Jing, SUO Qingxia. Serum EGFR and CA125 levels are correlated in women with adenomyosis pregnancy outcomes [J]. Basic & Clinical Medicine, 2025, 45(5): 658-663.
[3]	HAN Wei, PAN Wei, ZHANG Man, GAO Xiangyu, KANG Xinkai, ZHU Zhibo, LIU Ruiting. Scoparone inhibits proliferation and invasion of colon cancer cell line HCT116 [J]. Basic & Clinical Medicine, 2025, 45(11): 1429-1437.
[4]	SHEN Hongmei, YU Yan, FENG Xuqiang, WANG Keqiang. Usnea acid inhibits the proliferation of human ovarian cancer cell line [J]. Basic & Clinical Medicine, 2025, 45(1): 31-37.
[5]	CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng. Correlation between circulating CD4⁺CD45RA⁺CD62L⁺ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI [J]. Basic & Clinical Medicine, 2024, 44(5): 658-664.
[6]	LI Yuanchun, YAN Xueqian, FAN Dan, JI Yueru, XIAO Fang, GAO Jing. AP2M1 inhibits proliferation and invasion of diffuse large B-cell lymphoma cells [J]. Basic & Clinical Medicine, 2024, 44(3): 308-316.
[7]	Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping. Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer [J]. Basic & Clinical Medicine, 2024, 44(3): 303-307.
[8]	HUANG Jie, LI Runbo, GUO Jianxin, HAN Jian. Expression of DDX5 and DDX17 in ovarian cancer tissues and their effects on proliferation and drug resistance of human ovarian cancer cell line SKOV3 [J]. Basic & Clinical Medicine, 2023, 43(8): 1247-1253.
[9]	LENG Haina, ZHANG Yan, WANG Xiaodong, ZHANG Xueyou, LI Hongli. miR-767-5p inhibits the invasion of ovarian cancer cell lines by regulating the expression of TBL1XR1 protein [J]. Basic & Clinical Medicine, 2023, 43(3): 408-414.
[10]	TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing. Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer [J]. Basic & Clinical Medicine, 2023, 43(12): 1861-1865.
[11]	WANG Juan, ZHANG Xiao-yan, ZHU Ai-hua, YU Hong-bo, FAN Xin-dan, TANG Chun-hui, YAO Xiu-fang. High expression of Ku70 promotes proliferation of ovarian cancer cell lines and is associated with a poor prognosis for patients [J]. Basic & Clinical Medicine, 2022, 42(9): 1391-1399.
[12]	HAN Tian-tian, YIN Jie, ZENG Jing, JIN Ying, LI Yan, PAN Ling-ya. Establishment　and identification of an ovarian cancer cell strain stably expressing CDC50A [J]. Basic & Clinical Medicine, 2022, 42(6): 896-901.
[13]	YIN Jie, PAN Ling-ya, WEN Yi-ping, HUANG Hong, ZENG Jing, LI Xiao-ying, HAN Tian-tian, JIN Ying, LI Yan. Identification of bio-functions of cancer stem-like cells and differentially expressed membrane proteins in side population cells from human epithelial ovarian cancer cell lines [J]. Basic & Clinical Medicine, 2022, 42(2): 221-227.
[14]	DONG Hui, WANG Ting-ting, MA Xiao-hong, MA Sheng-zong, DING Yong-hui. Screening of differential lncRNAs and expression analysis of lncRNA ZEB2-AS1 in ovarian cancer tissues [J]. Basic & Clinical Medicine, 2022, 42(11): 1675-1680.
[15]	GAO Hong-yu, ZHANG Guo-ying, LIU Qiu-ju, WANG Ye, ZHANG Li, CHEN Chao. Thalidomide alleviates renal fibrosis of nephrotic syndrome mice [J]. Basic & Clinical Medicine, 2021, 41(9): 1291-1296.

Metrics

Viewed

Full text

Abstract

Comments

Abstract
References
Related Articles
Recommended Articles
Metrics
Comments

TOP